(Q40817947)

24 September 2017

title

Virus inactivation of plasma-derived proteins by pasteurization in the presence of guanidine hydrochloride (English)

1 reference

24 September 2017

Schlegel A

1

1 reference

24 September 2017

Immelmann A

series ordinal

2

1 reference

24 September 2017

Kempf C

series ordinal

3

1 reference

24 September 2017

publication date

1 March 2001

1 reference

24 September 2017

1 reference

24 September 2017

volume

41

1 reference

24 September 2017

issue

3

1 reference

24 September 2017

page(s)

382-389

1 reference

Pasteurization of antihemophilic factor and model virus inactivation studies

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41030382.X

Determination of adequate moisture content for efficient dry-heat viral inactivation in lyophilized factor VIII by loss on drying and by near infrared spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41030382.X

New methods for inactivation of lipid-enveloped and non-enveloped viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41030382.X

Inactivation of viruses by beta-propiolactone in human cryo poor plasma and IgG concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41030382.X

Virucidal treatment of blood protein products with UVC radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41030382.X

Nanofiltration, a new specific virus elimination method applied to high-purity factor IX and factor XI concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41030382.X

Virus inactivation by pepsin treatment at pH 4 of IgG solutions: factors affecting the rate of virus inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41030382.X

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41030382.X

Improved safety from plasma derivatives: purification and viral elimination characteristics of mononine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41030382.X

The transfusion-associated transmission of parvovirus B19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41030382.X

Intra- and extracellular modifications of apolipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41030382.X

Infection with TT virus, a novel transfusion-transmissible DNA virus, in haemophiliacs and in blood products

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41030382.X

10.1046/J.1537-2995.2001.41030382.X

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference